A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE … (NCT06322641) | Clinical Trial Compass
CompletedNot Applicable
A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
United States300 participantsStarted 2024-03-26
Plain-language summary
The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
* Male or female, age above or equal to 18 years at the time of signing informed consent.
* Is a Nephrologist.
* Has been in practice greater than or equal to 3 years.
* Sees at least 20 patients with ASCVD and CKD per month.
* Treats patients for more than only dialysis
Exclusion Criteria:
* Previous participation in this study. Participation is defined as having given informed consent in this study
* Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
* Does not meet inclusion criteria requirements
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study surveyed nephrologists about how they think about systemic inflammation in people who have both CKD and ASCVD — does my care team routinely check hsCRP as part of managing my condition, and if not, is it worth discussing?
2Since this was a survey-based study rather than a treatment trial, it focused on what doctors know and believe about inflammation as a risk factor — based on those kinds of findings, do you think residual inflammation might be playing a role in my cardiovascular risk beyond what my current treatments address?
3The study looked at whether nephrologists recognize the role of hsCRP as a biomarker in patients like me who have both kidney disease and heart disease — how would my hsCRP level actually change the way you manage my treatment, if at all?
4Given that this research was trying to identify gaps in how nephrologists approach inflammation in CKD and ASCVD patients, are there aspects of my inflammatory risk that you feel haven't been fully addressed in my current care plan?
5Since this study is already completed and was observational rather than testing a new treatment, are there any actual clinical trials testing anti-inflammatory therapies for people with my combination of CKD and cardiovascular disease that might be worth looking into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD